Page 27 - BEC / JULY / 2022

Global Medical

Isotope Market

Summary

The global radiopharmaceutical market is expected
to reach $30 billion US by 2030, with an annual
average growth of 16% between 2019 to 2030.

Diagnostic 48%
radiopharmaceutical of the world market (in value) was related
to 99M Tc-labeled tracers, additionally 10%
market is expected to
grow, on average, to the other SPECT agents in 2019
by 6% a year

77 companies
Therapeutic are sharing 33% of the world market
radiopharmaceutical 7 companies

accounted for 20% of the world market are controlling around 67%
in 2019, versus 6% in 2013 of the world market Credit - Canadian Nuclear Isotope Council (CNIC)
30% annual growth
in the therapeutic radiopharmaceutical 100+ companies
market is expected from 2019 to 2030
are currently developing one or
more radiopharmaceuticals from
their own pipeline

84 companies
are showing revenue in today’s nuclear medicine markets

Bruce Power’s production of Lutetium-177 adds and collaborations for our members and the global
tremendous capacity and stability to the supply. community. Fostering these relationships helps

The reliable supply of isotopes supports the entire advance the industries global supply chain.

ecosystem from research and development to
commercialization. Since its inception, the CNIC has achieved

tremendous growth, expanding from just 15
THE GLOBAL ADVANCEMENT member organizations to well over 76 members and

OF NUCLEAR ISOTOPES growing today. Its impact has been acknowledged

by multiple levels of government across Canada.

CNIC is quickly becoming a go-to reliable “Despite this progress, we’ve only just begun,” says
information source for government and industry. It Stephenson.

has held both North American and European trade For more information, please visit

missions to foster new business opportunities www.canadianisotopes.ca

JULY 2022 | BUSINESS ELITE CANADA 27